Atlas Trials

Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib

Clinical trial NCT01466972 · COMPLETED

Trial details

NCT number
NCT01466972
Sponsor
Hope Rugo, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBreast Neoplasm
Start date
2012-04-27
Primary completion
2015-12-07
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.